Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ningigo-P-20
- Development stage
- Unknown
- Lead developer
- Curis Lifecare
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Ningigo-P-20 is a fixed-dose combination tablet containing alprazolam (0.25 mg) and propranolol (20 mg), developed and marketed by Curis Lifecare. It is approved and used in India for the treatment of anxiety disorders. Alprazolam is a benzodiazepine that acts as a positive allosteric modulator of the gamma-aminobutyric acid type A (GABA-A) receptor, enhancing inhibitory neurotransmission to calm brain activity. Propranolol is a non-selective beta-adrenergic receptor antagonist that blocks the action of epinephrine and norepinephrine on beta-1 and beta-2 adrenergic receptors, thereby reducing physical symptoms of anxiety such as increased heart rate, palpitations, and elevated blood pressure.
- Brand names
- Ningigo-PNingigo-P-20Ningigo-P20Ningigo-P 20
- Other names
- alprazolam + propranolol
02
Targets
ADRB1 (β1)BZD site (GABA-A receptor benzodiazepine site)ADRB2 (β2)GABAA (Gamma-aminobutyric acid receptor)
Beyond the preview
Go deeper on Ningigo-P-20.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ningigo-P-20.